Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000472991 | SCV000544494 | benign | Tuberous sclerosis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001200216 | SCV000732256 | benign | not provided | 2019-05-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22903760) |
Ambry Genetics | RCV002257398 | SCV000849670 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001200216 | SCV001371116 | likely benign | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000472991 | SCV002039491 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257398 | SCV002533946 | benign | Hereditary cancer-predisposing syndrome | 2021-10-19 | criteria provided, single submitter | curation | |
Tuberous sclerosis database |
RCV000055330 | SCV000083550 | not provided | Lymphangiomyomatosis | no assertion provided | curation |